Courtagen Spotlight Gene Panels for Neurology and Endocrinology

Courtagen Life Sciences has launched 17 new gene panels in its Spotlight line of tests, expanding its menu in neurology, endocrinology, and other disease areas. The new tests include several pain-related panels, such as migraine, neuropathic pain, and abdominal pain. They also include endocrinology-related panels for hyper/hypoglycemia (MODY+), hyperparathyroidism, and pituitary hormone deficiency, and new neurology panels for neuromuscular disorders such as periodic paralysis, dystonia, and rhabdomyolysis.